Monica Sikka

Assistant Professor

  • 196 Citations
  • 7 h-Index
19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Monica Sikka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 196 Citations
  • 7 h-Index
  • 16 Article

Dalbavancin use in an academic medical centre and associated cost savings

Streifel, A. C., Sikka, M., Bowen, C. D. & Lewis, J. S., Jan 1 2019, (Accepted/In press) In : International Journal of Antimicrobial Agents.

Research output: Contribution to journalArticle

  • Experience of Chicagoland acute care hospitals in preparing for Ebola virus disease, 2014–2015

    Bleasdale, S. C., Sikka, M., Moritz, D. C., Fritzen-Pedicini, C., Stiehl, E., Brosseau, L. M. & Jones, R. M., Aug 3 2019, In : Journal of Occupational and Environmental Hygiene. 16, 8, p. 582-591 10 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Utilizing the focused conversation method in qualitative public health research: A team-based approach

    Fritzen-Pedicini, C., Bleasdale, S. C., Brosseau, L. M., Moritz, D., Sikka, M., Stiehl, E. & Jones, R. M., May 14 2019, In : BMC health services research. 19, 1, 306.

    Research output: Contribution to journalArticle

    Open Access
  • Pharmacokinetics of telavancin at fixed doses in normal- body-weight and obese (classes I, II, and III) adult subjects

    Bunnell, K. L., Pai, M. P., Sikka, M., Bleasdale, S. C., Wenzler, E., Danziger, L. H. & Rodvold, K. A., Apr 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 4, e02475-17.

    Research output: Contribution to journalArticle

    Open Access
  • 4 Scopus citations

    Phase I study to evaluate the pharmacokinetics, safety, and tolerability of two dosing regimens of oral fosfomycin tromethamine in healthy adult participants

    Antibacterial Resistance Leadership Group, Aug 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 8, e00464-18.

    Research output: Contribution to journalArticle

  • 3 Scopus citations